Using clinically stable disease (NEDA 2) as a proxy for disease impact and employment in MS paints an incomplete picture

J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):5. doi: 10.1136/jnnp-2019-321778. Epub 2019 Nov 14.
No abstract available

Keywords: multiple sclerosis.

Publication types

  • Editorial

MeSH terms

  • Disabled Persons
  • Disease Progression
  • Employment
  • Humans
  • Multiple Sclerosis / economics*
  • Multiple Sclerosis / psychology
  • Social Behavior
  • Unemployment / psychology
  • Unemployment / statistics & numerical data*